ON Semiconductor Corp. (NASDAQ:ONNN) reported its first-quarter profit more than doubled from a year ago and revenue increased almost 7 percent due to a current bookings rate at its highest level in two years. ON Semiconductor Corp (NASDAQ:ONNN) shares after opening at $8.87 moved to $9.03 on last trade day and at the end of the day closed at $8.88 . Company price to sales ratio in past twelve months was calculated as 1.41 and price to cash ratio as 6.25. ON Semiconductor Corp (NASDAQ:ONNN) showed a negative weekly performance of -6.03%.
Manitowoc Company, Inc. (NYSE:MTW) reported adjusted earnings from continuing operations of 17 cents per share, a year-over-year increase of 55% aided by sound performance in the Foodservice segment and new product introductions. The bottom line, however, fell short of the Zacks Consensus Estimate of 22 cents. Manitowoc Company, Inc. (NYSE:MTW) shares fell -10.16% in last trading session and ended the day on $29.00. MTW return on equity ratio is recorded as 20.40% and its return on assets is 3.50%. Manitowoc Company, Inc. (NYSE:MTW) yearly performance is 65.90%.
Yelp Inc (NYSE:YELP), which operates a consumer review site, reported its quarterly revenue this week. The company achieved a 66% jump in revenues during this time period. This has been possible mainly due to higher revenue from local advertising on mobile devices. The shares of this review site, which went public in March 2012, increased by 5% during extended trading on Wednesday. Yelp Inc (NYSE:YELP) shares moved down -6.65% in last trading session and was closed at $59.76 while trading in range of $59.72 – $65.14 – Yelp Inc (NYSE:YELP) year to date (YTD) performance is -13.33%.
Immunomedics, Inc(NASDAQ:IMMU) announced that it has priced its previously announced underwritten public offering pursuant to which the Company issued and sold an aggregate of 9,000,000 shares of its common stock, par value $0.01 per share (the “Common Stock”), at a purchase price of $3.35 per share, for aggregate gross proceeds of approximately $30,150,000, before deducting estimated fees and expenses associated with the offering (the “Offering”). Pursuant to the terms of the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among the Company and Wells Fargo Securities, LLC and Jefferies LLC (collectively, the “Underwriters”), the Company granted to the Underwriters a 30-day option to purchase up to an additional 1,350,000 shares of Common Stock. Immunomedics, Inc. (NASDAQ:IMMU) weekly performance is -18.43%. On last trading day company shares ended up $3.23. Immunomedics, Inc. (NASDAQ:IMMU) distance from 50-day simple moving average (SMA50) is -27.62%. Analysts mean target price for the company is $7.75.